A review of 10 articles finds that nearly 9% of adverse event (AE) reports with biologics used to treat psoriasis were gastrointestinal (GI)-related and suggests that the relative rate may be higher ...

Patients needing costly biologic drugs for autoimmune and chronic conditions often face insurance denials that delay or block treatment. With strong medical documentation, standardized appeal ...